I am an Associate Professor of Biochemistry and Molecular Biology at Howard University, Washington D.C. I obtained my PhD in Molecular Biology from Queen Mary & Westfield College (University of London, UK) where I carried out studies using Cre-loxP site-specific recombination system to design chromosomal translation in transgenic animal model. I carried out my post-doctoral training at Baylor College of Medicine, Houston TX where I undertook research studies of the molecular mechanisms underlying dys-regulation of receptor tyrosine signaling in prostate cancer. I subsequently joined Howard University cancer Center in 2007 as an Assistant Professor and become an Associate Professor in 2011. Currently, I serve as a Principle Investigator of a prostate cancer research laboratory. The focus of my research is 3 fold: First, to understand the role of epigenetic alterations in regulating gene expression in prostate cancer. Second, to evaluate and implement tools for quantitative DNA methylation analysis in support of differences in prostate cancer tumor biology and prostate cancer disparity and finally, to understand how DNA methylation changes can be explored as potential biomarkers (ethnic sensitive biomarkers) for the early detection of cancer and/or progression of the disease.